US Patent Issued to SIMCERE PHARMACEUTICAL, JIANGSU SIMCERE PHARMACEUTICAL on Oct. 6 for "Stable pharmaceutical compositions of edaravone and dextrocamphol" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,941, issued on Oct. 6, was assigned to SIMCERE PHARMACEUTICAL Co. LTD. (Nanjing, China) and JIANGSU SIMCERE PHARMACEUTICAL Co. LTD. (Nanjing, China).

"Stable pharmaceutical compositions of edaravone and dextrocamphol" was invented by Yong Qian (Nanjing, China), Xia Wang (Nanjing, China), Xi Zhu (Nanjing, China), Cuncun Liu (Nanjing, China), Feng Wang (Nanjing, China) and Jinsheng Ren (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A stable pharmaceutical composition contains active ingredients of edaravone and dextrocamphol can control the content of unique impurity SCR-756 and impurity SCR-757 thereof."

The patent was filed on Aug. 1...